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Contribution of Different Scintigraphic Techniques to the Management
of Medullary Thyroid Carcinoma
Dirk Sandrock,* Hans-Christian Blossey,* Martina Steinroeder,* and Dieter L . Munz*

We compared three differenl scintigraphic techniques for the localization of neck recurrences and
metastases in seven patients wiih medullary thyroid carcinoma one monlh lo eight years after thefirst
surgical intervention. Three successive scintigraphic studies were performed in five patients (6x3
studies) wilhin two weeks using -"'Tl chloride, '"In-labeled F(ah'), fragments of the anticarcinoembryonic antigen (anti-CEA) monoclonal antibody (MoAh) BW 431131. and '"/ meta-iodobenzylguanidine (MIBG). Additionally. 11 studies were performed wilh the '"In-labeled MoAb
fragment BW 431131 (seven studies) or the ''"'"Tc-labeled intact anti-CEA MoAb BW 431126 (four
studies). The gold .standards for classifying scintigraphic resuUs were biopsy, histology, surgery, and
cytology. Six regions were classified as positive or negalive in each study: thyroid region, four
quadrants (lymph node regions) around the thyroid, and the region of the upper media.stinum. Of 36
sites, ^'"Tl was true positive (TP) in seven sites, false-positive (FP) in one site, true negative (TN) in 22
sites, andfalse-negative (FN) in six sites, resulting in a sensitivity of54% and a specificity of 96%. '-"/
MIBG was TP in four sites, FP in none of the siles, TN in 23 siles, and FN in nine sites, with a
sensitivity of31% and a specificity of 100%. Immunoscintigraphy (102 .sites overall) was TP in 16 siles,
FP infivesiles, TN in 77 siles, and FN in four siles. resulting in a .sensitivity of 80% and a specificity of
94%. Immunoscintigraphy with "'lnl^'"Tc anti-CEA F(ab' )2 fragment I intact antibody is superior lo
scintigraphy with -"'Tiand '"I MIBG. (Henry Ford Hosp MedJ 1989:37:173-4)

S

everal approaches with different radiotracers have been
reported for the localization and treatment of medullary
thyroid carcinoma (MTC) (1-6) in addition to serum levels of
calcitonin (CT) and carcinoembryonic antigen (CEA) as
tumor markers.
We compared different scintigraphic methods (-'"Tl, " ' I
meta-iodo-benzylguanidine IMIBG], and immunoscintigraphy)
for the localization of neck recurrences and metastases in patients with MTC and for the assessment of the value of immunoscintigraphy for the follow-up ofthese patients.

Methods
Seven patients with MTC were studied one month to eight
years after first surgical intervention (usually total thyroidectomy and/or neck dissection). Patients included three men and
four women, aged 22 to 65 at the time of first scintigraphy. Six
had a sporadic MTC and one also had a pheochromocytoma.
Overall, 29 scintigraphic studies were performed; in five patients, six intraindividual comparisons were performed within
two weeks with all three tracers (6 x 3 = 18 studies). Additionally, I I studies were performed using immunoscintigraphy
alone.
For -"'Tl studies, 74 MBq '"'Tl chloride was given intravenously and scintigraphic images obtained 10 to 90 minutes
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postinjection. Twenty-six MBq " ' I MIBG were injected intravenously, and scintigraphy was performed one. two, and, if necessary, five days postinjection. For immunoscintigraphy, we
used 185 MBq '"In-labeled F(ab'), fragments of the anti-CEA
monoclonal antibody BW 431/31 intravenously with scintigraphy one and two days postinjection (13 studies) or 740 MBq
""Tc-labeled intact anti-CEA monoclonal antibody BW 431/26
with scintigraphy 4.5 and 24 hours postinjection (four studies).
Studies using emission computed tomography were also done i f
appropriate.
In each study, six regions were classified as positive or negafive; thyroid region, four lymph node quadrants around the thyroid, and the upper mediastinal region. The gold standards for
classification as true or false positive/negative were biopsy, surgery, histology, or cytology. Computed tomography or ultrasonography demonstrated partly normal, partly equivocal
findings.
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Table
Results of Scintigraphy in Medullary Thyroid Carcinoma
Tracer

Siles

TP

FP

1
36
7
»'T1 chloride
4
t)
36
" ' I MIBG
5
"'In. 'Jc MoAb
102
16
TP = true positive, FP = false-positive, TN
negative.

TN

FN Sensitivity Specificity

6
54%
96%
22
23
9
31%
100%
4
80%
94%
77
- tnie negative, and FN = false-

Results
Overall, 13 of 36 regions (^"'TI, MIBG studies) were positive
with tumor recurrence or lymph node metastases as proven by
histology or cytology. In the larger group with immunoscintigraphic studies, 20 of 102 regions were tumor positive; eight
local recunences in the thyroid area, four lymph node metastases in the upper quadrant (cervical), six lymph node metastases
in the lower quadrant (lower jugular vein and supraclavicular),
and two lymph node metastases in the upper mediastinum. The
size of the tumor deposits detected by scintigraphy ranged from
1.5 to 4 cm in diameter Attimeof first study, seram CEA was
elevated in four patients, normal in two patients, and not available in one patient. CT was positive in tliree patients, negative in
three patients, and not available in one patient.
Immunoscintigraphy detected 16 sites correctly (true
positive) and missed four sites (false-negative). A total of 77
sites were classified as true negative, and five false-positive
spots were seen. In att parients with false-negative or falsepositive spots, at least one trae positive site was detected.
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With -"'Tl chloride, seven sites were tme positive and six were
false-negative. Twenty-two regions were trae negative and one
spot was false-positive. Using ' " I MIBG, only four sites were
trae positive while nine sites were missed (false-negative). Atl
23 sites were trae negative (no false-positive). The Table gives
the appropriate numbers and the sensitivity and specificity
values.
Immunoscintigraphy with '"In-labeled anti-CEA F(ab')2
fragments or ""Tc-Iabeled intact anti-CEA monoclonal antibody is superior to scintigraphy with -"'Tl chloride and " ' I
MIBG.
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